Corentin Herbert

Corentin Herbert has a comprehensive work experience in the field of research and leadership roles. Corentin currently holds the position of Director, Translational Research at Alentis Therapeutics since September 2023. Prior to this, they worked at Pfizer as the Director of Cell Biology & In Vitro for the Rare Disease Research Unit from June 2020 to August 2023. Before Pfizer, Corentin served as a Group Leader for in vitro pharmacology at Evotec from April 2015 to June 2020. Corentin also worked at Sanofi as a Group Leader from February 2010 to April 2015 and as a Senior Research Scientist from July 2005 to January 2010. Corentin had a post-doctoral position at sanofi-aventis from October 2003 to March 2005. Corentin started their career with a PhD in the field of Plant-Microbe Interactions at Université Paul Sabatier and CNRS from September 1999 to August 2003, which was awarded the silver medal of the French Academy of Agriculture.

Corentin Herbert received their education in the following order:

1. From 1992 to 1996, they obtained a Master's degree in Cellular Biology and Animal Physiology from Nantes Université.

2. From 1996 to 1997, they pursued a Master's degree in Plant Molecular Biology and Phytopathology at Université Paul Sabatier Toulouse III.

3. Corentin continued their studies at the same university from 1998 to 1999, where they earned a Postgraduate degree in Plant Molecular Biology – Phytopathology.

4. Finally, from 1999 to 2003, they obtained a Doctor of Philosophy (PhD) in Plant Pathology/Phytopathology from Université Paul Sabatier - Toulouse III.

Note: There is no information provided about their education prior to 1992 or after 2003.